Theragene Pharmaceuticals Company

Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.


Investors

Founded Date: 2011
Last Funding Type: Convertible Note
Headquarters: San Diego, California, United States
Investors Number: 1
Technology: Cancer
Employee Number: 1-10
Industry: Biotechnology, Pharmaceutical, Therapeutics
Estimated Revenue: $1M to $10M
Last Funding Date: 2017
Funding Status: Early Stage Venture
Investor Type: Early Stage Venture
Total Funding: 548000